CLTR COULTER PHARMACEUTICAL Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CLTR COULTER PHARMACEUTICAL

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Pseudo Biologist who wrote (400)	11/23/1999 9:43:00 PM
From: dmkst1	of 666

Very nice board you folks have over here. Concerning the application and review process it seems to me that CLTR still has a time advantage given that it was fast-tracked and I don't think zevalin was. Since the application was not accepted - upon acceptance of the application the FDA would them have 6 months to act on it. If progresses well there would be no need for a fast-track to zevalin which could receive a review of a year or more. What does everybody think. Bob

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next